Infectious Disease Diagnostics Market, By Technique,By Disease Indication, Diarrheal Disease,Respiratory Infections,Blood Infections,STDs),By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023

Description

Infectious diseases are caused by organisms such as bacteria, virus, fungi, and parasites and are capable of transmission from one species to another species. Infectious diseases spread from person to person either through direct contact or indirectly through insect bites or other vectors like food, soil, water, and air. Diagnosis of these diseases involves identifying the pathogen and its type and then diagnose infection has spread. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. Infectious diseases are among the leading causes of morbidity and death. Diagnostics plays important part in deciding the course of any clinical treatment. While Infectious diseases diagnostics help in diagnosing disease caused because of pathogenic disease Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Traditional infectious disease diagnosis was time-consuming. Because of this factor, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. Point of care testing helps for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, conventional culturing, and staining techniques. Biochemical techniques include Enzyme-linked Immunosorbent Assay (ELISA), agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Market Dynamics

Increasing prevalence of Infectious Disease Diagnostics Market is expected to drive the market growth over the forecast period, due to growing awareness for the early disease diagnostics. For instance, In 1995, According to the Centers for Disease Control and Prevention {CDCP}, Hospital-acquired infections( HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all, the urinary tract infections occurs up to 32% of all the healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections [14%].

Key features of the study:

This report provides in-depth analysis of the global infectious disease diagnostics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global infectious disease diagnostics market based on the following parameters -company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
Global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation:

Global Infectious Disease Diagnostics Market, By Technology :
- ELISA
- Polymerase Chain Reaction
- Immunoassays
- Cell Cultures
- Others
Global Infectious Disease Diagnostics Market, By Disease Indication:
- Central nervous system (CNS) Infection
  - Meningitis
  - Brain Abscess
- Diarrheal Disease
  - Shigellosis
  - Cholera
  - Enteric/Typhoid Fever
- Respiratory Infections
  - Tuberculosis
  - Influenza
  - Bronchitis
- Blood Infections
  - Malaria
  - Dengue
  - Infectious Mononucleosis
  - Others
- STDs
  - Chlamydia
  - AIDS
  - Syphilis
  - Others
Global Infectious Disease Diagnostics Market, By End User:
- Hospitals
- Diagnostics centers
- Dermatology Clinics
- Others (Research Institutes, Specialty Centres, etc.)
Global Infectious Disease Diagnostics Market , By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Becton Dickinson & Company *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments
- Cepheid, Inc.
- Abbott Laboratories
- BioMerieux SA
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- DiaSorin S.p.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1971

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Disease Indication
- Market Snapshot, By End Users
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
- Product Launches
- Merger, Acquisition, Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis

4. Global Infectious Disease Diagnostics Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Infectious Disease Diagnostics Market, By Technology, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
- Segment Trends
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Segment Trends
Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Segment Trends
Cell Cultures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
- Segment Trends

6. Global Infectious Disease Diagnostics Market , By Disease Indication 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Central Nervous System Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Meningitis
Brain Abscess
Diarrheal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Shigellosis
Cholera
Enteric/Typhoid Fever
Respiratory Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Tuberculosis
Influenza
Bronchitis
Blood Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Malaria
Dengue
Infectious Mononucleosis
Others
Sexually transmitted diseases (STDs),
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Chlamydia
AIDS
Syphilis
Others

7. Global Infectious Disease Diagnostics Market , By End Users 2017 - 2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)
Others (Research Institutes, Specialty Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Mn)

8. Global Infectious Disease Diagnostics Market , By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, Technology , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017- 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Becton Dickinson & Company
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Cepheid, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Abbott Laboratries
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
BioMerieux
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Danaher Corportion
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Roche Diagnostics
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
DiaSorin S.p.A.
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Quidel Corporation
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc
- Company Overview
- Product Portfolio
- Key Development
- Financial Performance
- Strategies

10. Section

Research Methodology
About Us

Infectious Disease Diagnostics Market, By Technique,By Disease Indication, Diarrheal Disease,Respiratory Infections,Blood Infections,STDs),By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030